Insurers ending waivers on COVID-19 treatment fees

The voluntary waiving of COVID-19 treatment fees by insurers is slowly coming to an end, according to NBC News and Kaiser Health News.

Advertisement

While testing for the virus remains free, payers including UnitedHealth, Anthem and Aetna are no longer waiving the costs of physician visits, hospital care, medications or other treatment. While Humana continues to waive fees for its Medicare Advantage members, it no longer provides such an option to those in job-based plans. 

Insurers Premera Blue Cross in Washington and Sharp Health Plan in California have extended cost-sharing waivers through June. Kaiser Permanente has not set an end date.

More articles on payers:
Stanford Health Care sues Anthem, alleges breach of implied contract
Cigna accuses Connecticut physician practice of price gouging
Oscar Health launches technology business: 3 things to know

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.